Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
JAMA Dermatology
|
June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated Genotypes
Isabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 21, 2025
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden
Meghan Anderson, Defne Ercelen, Ashley Richardson, et al.
Journal of Clinical Medicine
|
February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome
David B Beck, Maël Heiblig, Sinisa Savic, et al.
Rheumatology (Oxford, England)
|
March 29, 2024
Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome
Daniela Ospina Cardona, Ignasi Rodriguez-Pinto, Sonia Iosim, et al.
Frontiers in Neuroscience
|
November 16, 2020
Human iPSC-Derived Neuronal Cells From <i>CTBP1</i>-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene Networks
S Vijayalingam, Uthayashanker R Ezekiel, Fenglian Xu, et al.
Blood
|
March 10, 2021
Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
James A Poulter, Jason C Collins, Catherine Cargo, et al.
Genes & Development
|
March 8, 2013
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano, Paloma Martínez-Redondo, Anna Marazuela-Duque, et al.
Annals of Internal Medicine
|
January 20, 2025
Germline <i>UBA1</i> Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic Syndrome
Maria Creignou, Maria Sirenko, Pedro L Moura, et al.
Neurogenetics
|
April 21, 2016
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
David B Beck, Megan T Cho, Francisca Millan, et al.
European Journal of Haematology
|
February 15, 2023
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation
Hannah Cherniawsky, Jordan Friedmann, Hamish Nicolson, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
JAMA Dermatology
|
June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated Genotypes
Isabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 21, 2025
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden
Meghan Anderson, Defne Ercelen, Ashley Richardson, et al.
Journal of Clinical Medicine
|
February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome
David B Beck, Maël Heiblig, Sinisa Savic, et al.
Rheumatology (Oxford, England)
|
March 29, 2024
Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome
Daniela Ospina Cardona, Ignasi Rodriguez-Pinto, Sonia Iosim, et al.
Frontiers in Neuroscience
|
November 16, 2020
Human iPSC-Derived Neuronal Cells From <i>CTBP1</i>-Mutated Patients Reveal Altered Expression of Neurodevelopmental Gene Networks
S Vijayalingam, Uthayashanker R Ezekiel, Fenglian Xu, et al.
Blood
|
March 10, 2021
Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
James A Poulter, Jason C Collins, Catherine Cargo, et al.
Genes & Development
|
March 8, 2013
The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation
Lourdes Serrano, Paloma Martínez-Redondo, Anna Marazuela-Duque, et al.
Annals of Internal Medicine
|
January 20, 2025
Germline <i>UBA1</i> Variant With Somatic Amplification in a Woman With Inflammatory Diseases and Myelodysplastic Syndrome
Maria Creignou, Maria Sirenko, Pedro L Moura, et al.
Neurogenetics
|
April 21, 2016
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
David B Beck, Megan T Cho, Francisca Millan, et al.
European Journal of Haematology
|
February 15, 2023
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation
Hannah Cherniawsky, Jordan Friedmann, Hamish Nicolson, et al.
Page
of 9